53
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Improving Assessment of Adherence Behaviors and Drivers: Targeted Literature Review and Concept Elicitation Interviews in Multiple Countries and Disease Populations

, , ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 1231-1242 | Received 29 Nov 2023, Accepted 29 May 2024, Published online: 17 Jun 2024

References

  • De Geest S, Sabaté E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003;2(4):323. doi:10.1016/S1474-5151(03)00091-4
  • Steiner JF, Earnest MA. The language of medication-taking. Ann Internal Med. 2000;132(11):926–930. doi:10.7326/0003-4819-132-11-200006060-00026
  • Brown MT, Bussell JK. Medication Adherence: WHO Cares? Elsevier; 2011:304–314.
  • Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med Journal. 2011;26(3):155. doi:10.5001/omj.2011.38
  • Cheen MHH, Tan YZ, Oh LF, Wee HL, Thumboo J. Prevalence of and factors associated with primary medication non‐adherence in chronic disease: a systematic review and meta‐analysis. Int J Clin Pract. 2019;73(6):e13350. doi:10.1111/ijcp.13350
  • Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Preventive Med. 2017;99:269–276. doi:10.1016/j.ypmed.2017.03.008
  • Khunti K, Seidu S, Kunutsor S, Davies M. Association between adherence to pharmacotherapy and outcomes in type 2 diabetes: a meta-analysis. Diabetes Care. 2017;40(11):1588–1596. doi:10.2337/dc16-1925
  • Fitzpatrick C, Gillies C, Seidu S, et al. Effect of pragmatic versus explanatory interventions on medication adherence in people with cardiometabolic conditions: a systematic review and meta-analysis. BMJ Open. 2020;10(7):e036575. doi:10.1136/bmjopen-2019-036575
  • Ahmad A, Sorensen K. Enabling and hindering factors influencing adherence to asthma treatment among adolescents: a systematic literature review. J Asthma. 2016;53(8):862–878. doi:10.3109/02770903.2016.1155217
  • Hanghøj S, Boisen KA. Self-reported barriers to medication adherence among chronically ill adolescents: a systematic review. J Adolesc Health. 2014;54(2):121–138. doi:10.1016/j.jadohealth.2013.08.009
  • Huang W-C, Chen C-Y, Lin S-J, Chang C-S. Medication adherence to oral anticancer drugs: systematic review. Expert Rev Anticancer Ther. 2016;16(4):423–432. doi:10.1586/14737140.2016.1159515
  • Macdonald M, Martin-Misener R, Helwig M, et al. Experiences of adults with cystic fibrosis in adhering to medication regimens: a qualitative systematic review. JBI Datab System Rev Implement Rep. 2016;14(5):258–285. doi:10.11124/JBISRIR-2016-002362
  • McSharry J, McGowan L, Farmer A, French D. Perceptions and experiences of taking oral medications for the treatment of Type 2 diabetes mellitus: a systematic review and meta‐synthesis of qualitative studies. Diabetic Med. 2016;33(10):1330–1338. doi:10.1111/dme.13152
  • Rebafka A. Medication Adherence After Renal Transplantation—a Review of the Literature. J Renal Care. 2016;42(4):239–256. doi:10.1111/jorc.12181
  • Rezaei M, Valiee S, Tahan M, Ebtekar F, Gheshlagh RG. Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study. Diabetes Metabol Synd Obes. 2019;12:589. doi:10.2147/DMSO.S197159
  • Dockerty T, Latham S, Smith T. Why don’t patients take their analgesics? A meta-ethnography assessing the perceptions of medication adherence in patients with osteoarthritis. Rheumatol Int. 2016;36(5):731–739. doi:10.1007/s00296-016-3457-8
  • Lin C, Clark R, Tu P, Bosworth HB, Zullig LL. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers. Breast Cancer Res Treat. 2017;165(2):247–260. doi:10.1007/s10549-017-4317-2
  • Vitalis D. Factors affecting antiretroviral therapy adherence among HIV-positive pregnant and postpartum women: an adapted systematic review. Int J STD AIDS. 2013;24(6):427–432. doi:10.1177/0956462412472807
  • US Food and Drug Administration (FDA), Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims; 2009 Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims.
  • US Food and Drug Administration (FDA), Patient-focused drug development: collecting comprehensive and representative input; guidance for industry, food and drug administration staff, and other stakeholders; 2020 Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-focused-drug-development-collecting-comprehensive-and-representative-input.
  • US Food and Drug Administration (FDA), Patient-focused drug development: methods to identify what is important to patients guidance for industry, food and drug administration staff, and other stakeholders; 2022 Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-focused-drug-development-methods-identify-what-important-patients.
  • Willis GB Cognitive Interviewing: A tool for improving questionnaire design (National Cancer Institute). 2004.
  • Bentley SM, Morgan L, Exall E, Arbuckle R, Rossom RC, Roche N, Khunti K, Higgins V, Piercy J. Qualitative interviews to support development and cognitive debriefing of the Adelphi Adherence Questionnaire (ADAQ©): A patient-reported measure of medication adherence developed for use in a range of diseases, treatment modalities, and countries. Patient Prefer Adherence. 2022;15(16):2579–2592. doi:10.2147/PPA.S358046.
  • ATLAS.ti Scientific Software Development GmbH, ATLAS.ti (version 8) [Qualitative data analysis software] https://atlas.com ; 2020.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa
  • Bentley SM, Exall L, Roberts A, Rossom R, Roche N, Khunti K, Higgins V, Arbuckle R, Piercy J. Cognitive debriefing of the Adelphi Adherence Questionnaire (ADAQ©): a novel generic patient-reported measure of medication adherence drivers and behaviours. International Society of Quality of Life Research (ISOQOL); 2021.
  • Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res. 2010;10(3):269–281. doi:10.1586/erp.10.30
  • Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11(2):54–65. doi:10.3121/cmr.2013.1113
  • Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437–443. doi:10.1592/phco.28.4.437
  • World Health Organization. Adherence to long-term therapies. Available from: https://www.who.int/chp/knowledge/publications/adherence_full_report.pdf. Accessed September 24, 2021.
  • Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17(10):756–765. doi:10.1046/j.1525-1497.2002.11214.x
  • Brown TM, Siu K, Walker D, Pladevall-Vila M, Sander S, Mordin M. Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation. J Managed Care Pharm. 2012;18(5):351–362. doi:10.18553/jmcp.2012.18.5.351
  • Mayberry LS, Osborn CY. Empirical validation of the information–motivation–behavioral skills model of diabetes medication adherence: a framework for intervention. Diabetes Care. 2014;2:131828.
  • Jaam M, Ibrahim MM, Kheir N, Awaisu A. A proposed holistic conceptual framework for barriers to medication adherence in diabetes. Value Health. 2016;19(7):A676–A677. doi:10.1016/j.jval.2016.09.1897